References
Kousoulis, A.A., Angelopoulou, K.E., Lionis, C.: Exploring health care reform in a changing Europe: Lessons from Greece. Eur J Gen Pract 19(3), 194–199 (2013)
Vandoros, S., Hessel, P., Leone, T., Avendano, M.: Have health trends worsened in Greece as a result of the financial crisis? A quasi-experimental approach. Eur J Public Health 23(5), 727–731 (2013)
Eris M. (2012): Improving Health Outcomes and System in Hungary. OECD Economics Department Working Papers, No. 961. OECD
Gaál, P., Sz, Szigeti, Panteli, D., Gaskins, M., van Ginneken, E.: Major challenges ahead for Hungarian health care; The health sector in Hungary is facing its most serious crisis since the fall of the communist regime. BMJ 343, d7657 (2011). doi:10.1136/bmj.d7657
OECD 2010, “Health care systems: Getting more value for money”, OECD Economics Department Policy Notes, No. 2
Baji, P., Boncz, I., Jenei, G., Gulácsi, L.: Comparing cost-sharing practices for pharmaceuticals and health care services among four Central European countries. Society and Economy 34(2), 221–240 (2012)
Pavlova, P., Arsenijevic, J., Goot, W., van Merode, G.G.: Projection of health service consumption and patient payment revenues in CEE countries using system dynamics modeling. Society and Economy 34(2), 359–378 (2012)
Baji, P., Pavlova, M., Gulácsi, L., Groot, W.: User fees for public health care services in Hungary: Expectations, experience, and acceptability from the perspectives of different stakeholders. Health Policy 102(2–3), 255–262 (2011)
Karanikolos, M.M.P., Cylus, J., Thomson, S., Basu, S., Stuckler, D., Mackenbach, J.P., McKee, M.: Financial crisis, austerity, and health in Europe. Lancet 381, 1323–1331 (2013)
McCormick, J., Mehta, G., Olesen, H.V., Viviani, L., Macek Jr, M., Mehta, A.: European Registry Working Group Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet 375(9719), 1007–1013 (2010)
European Cystic Fibrosis Society. Patient Registry Report 2007 Data. http://www.ecfs.eu/projects/ecfs-patient-registry/annual-reports
Érsek, K., Kovács, T., Wimo, A., Kárpáti, K., Brodszky, V., Péntek, M., Jönsson, L., Gustavsson, A., McDaid, D., Kenigsberg, P.A., Valtonen, H., Gulácsi, L.: Costs of dementia in Hungary. J. Nutrition Health Aging 14(8), 633–639 (2010)
Péntek, M., Horváth, C., Boncz, I., Falusi, Z., Tóth, E., Sebestyén, A., Májer, I., Brodszky, V., Gulácsi, L.: Epidemiology of osteoporosis related fractures in Hungary from the nationwide health insurance database, 1999-2003. Osteoporos. Int. 19(2), 243–249 (2008)
Sebestyén, A., Boncz, I., Sándor, J., Nyárády, J.: Effect of surgical delay on early mortality in patients with femoral neck fracture. Int. Orthop. 32(3), 375–379 (2008)
Boncz, I., Sebestyén, A., Pintér, I., Betlehem, J., Kriszbacher, I., Csere, T., Mangel, L., Bódis, J.: Age group specific gap between treatment cost of and mortality due to breast and colorectal cancer. J. Clin. Oncol. 25(28), 4501–4502 (2007)
Boncz, I., Sebestyén, A., Pintér, I., Battyány, I., Ember, I.: The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities. J. Med. Screen. 15(1), 14–17 (2008)
Laki, J., Mónok, G., Pálosi, M., Gajdácsi, J.Z.: Economical aspect of biological therapy in inflammatory conditions in Hungary. Expert Opin Biol Ther. 13(3), 327–337 (2013)
Minier, T., Péntek, M., Brodszky, V., Ecseki, A., Kárpáti, K., Polgár, A., Czirják, L., Gulácsi, L.: Cost-of-illness of patients with systemic sclerosis in a tertiary care centre. Rheumatology (Oxford) 49(10), 1920–1928 (2010)
Inotai, A., Rojkovich, B., Fülöp, A., Jászay, E., Agh, T., Mészáros, A.: Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis. Rheumatol. Int. 32(4), 963–969 (2012)
Putrik, P., Ramiro, S., Kvien, T.K., Sokka, T., Uhlig, T., Boonen, A.: on behalf of Equity in Clinical Eligibility Criteria for RA treatment Working Group. Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country’s wealth? Ann. Rheum. Dis. (2013). doi:10.1136/annrheumdis-2013-203819
Antonanzas, F., Rodriguez-Ibeas, R.: Channeling health economics research initiatives to improve decision-making process in EU. Eur. J Health Econ 14, 847–852 (2013)
Kaló, Z., Landa, K., Dolezal, T., Vokó, Z.: Transferability of National Institute for Health and Clinical Excellence recommendations for pharmaceutical therapies in oncology to Central-Eastern European countries. Eur. J. Cancer Care (2012). doi:10.1111/j.1365-2354.2012.01351.x
Gulácsi, L., Orlewska, E., Péntek, M.: Health economics and health technology assessment in Central and Eastern Europe: a dose of reality. Eur J Health Econ 13(5), 525–531 (2012)
Ozieranski, P., McKee, M., King, L.: The politics of health technology assessment in Poland. Health Policy 108(2–3), 178–193 (2012)
Jóna G., A GYEMSZI Technológia-értékelő Főosztály tapasztalataiból. Corvinus Health Policy Series Conference 2011.10.03. Budapest
Cleemput, I., Neyt, M., Thiry, N., de Laet, C., Leys, M.: Using threshold values for cost per quality-adjusted life year gained in health care decisions. Int. J. Technol. Assess. Health Care 27, 71–76 (2011)
McCabe, C., Claxton, K., Culyer, A.J.: The NICE Cost-Effectiveness threshold. What it is and What that Means, Pharmacoeconomics 26(9), 733–744 (2008)
Acknowledgments
The authors are grateful to Petra Baji, Valentin Brodszky (Corvinus University of Budapest), Professor Devidas Menon (Department of Public Health Sciences, School of Public Health, University of Alberta), Prof. David Banta, Prof. Egon Jonsson (Institute of Health Economics, University of Alberta, University of Calgary), Chris Sargent (Managing Director, Health Technolgy Assessment International, HTAi, Institute of Health Economics, Alberta), Tara Schuller (INAHTA Secretariat, Institute of Health Economics, Alberta), and Olga Loblova (Central European University, Budapest), and special thanks to Ildikó Kaposi (American University in Kuwait), for their contribution.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gulácsi, L., Péntek, M. HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain. Eur J Health Econ 15, 675–680 (2014). https://doi.org/10.1007/s10198-014-0608-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-014-0608-2